SOBI — Swedish Orphan Biovitrum AB (publ) Share News
0.000.00%
Last trade - 00:00- SEK165.02bn
- SEK180.18bn
- SEK28.24bn
SOBI slips after Ionis lowers Tryngolza sales forecast
Brief: Swedish Orphan Biovitrum Executive Sells, Buys Shares
Europe Research Roundup: Centrica, Fuchs, URW
Brief: Swedish Orphan Biovitrum Proposes Börje Ekholm As New Chair And Board Member At 2027 AGM
Brief: SOBI's Pozdeutinurad Meets Phase 3 Primary Endpoint In REDUCE-2
Brief: Sobi Raises Outlook For 2026 Revenue Growth
Health Rounds: Researchers find a possible trigger of some preterm births
Europe Research Roundup: Bankinter, Santander, Volex
RCS - Accession Theraptcs. - Accession Therapeutics: Board appointments
Brief: SOBI Receives Positive CHMP Opinion For Tryngolza
Brief: SOBI Enters Strategic Partnership With Innate Pharma To License Lacutamab In T-Cell Lymphoma
BioNTech says Sobi's Oelkers will replace Sahin as CEO (updated)
BioNTech says Sobi's Oelkers will replace Sahin as its CEO
Brief: SOBI CEO Guido Oelkers To Step Down In The Beginning Of 2027
Brief: SOBI Executive Wesström Divested Around SEK 4.6 Mln Worth Of Shares
Europe Research Roundup: BMW, SMA Solar, Vodafone Group
Sweden's SOBI Q2 revenue beats estimates on higher sales, portfolio expansion
Brief: SOBI Updates Guidance For 2026
Europe Research Roundup: Maersk, Sika, Wizz Air